Anaptysbio (ANAB) Non-Current Debt (2016 - 2018)

Anaptysbio (ANAB) reported Non-Current Debt of $625000.0 for Q4 2018, down 91.73% on a YoY basis from $7.6 million in Q4 2017, and down 74.06% quarter-over-quarter from $2.4 million in Q3 2018.

Anaptysbio (ANAB) Non-Current Debt (2016 - 2018) Analysis & Trends

Anaptysbio has reported Non-Current Debt for 3 years, with the latest figure at $625000.0 in Q4 2018.

  • For the quarter ending Q4 2018, Non-Current Debt fell 91.73% year-over-year to $625000.0; the trailing twelve-month figure through Dec 2018 stood at $625000.0 (down 91.73% YoY), and the FY2018 full-year result was $625000.0, down 91.73% from the prior year.
  • Non-Current Debt for Q4 2018 stood at $625000.0, down from $2.4 million in the prior quarter.
  • The five-year high for Non-Current Debt was $13.8 million in Q4 2016, with the low at $625000.0 in Q4 2018.
  • Historically, Non-Current Debt has averaged $7.5 million across 3 years, with a median of $7.6 million in 2017.
  • Annual changes were most pronounced in 2017 — Non-Current Debt tumbled 45.3% — and 2018, when it tumbled 91.73%.
  • Anaptysbio's Non-Current Debt stood at $13.8 million in 2016, then plunged by 45.3% to $7.6 million in 2017, then plunged by 91.73% to $625000.0 in 2018.
  • The last three Non-Current Debt figures came in at $625000.0 (Q4 2018), $2.4 million (Q3 2018), and $4.1 million (Q2 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 319.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Anaptysbio 1.66 Bn 1.38 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2018 625,000.00
Dec 31, 2018 625,000.00
Sep 30, 2018 2.41 Mn
Sep 30, 2018 2.41 Mn
Jun 30, 2018 4.12 Mn
Jun 30, 2018 4.12 Mn
Mar 31, 2018 5.83 Mn
Mar 31, 2018 5.83 Mn
Dec 31, 2017 7.55 Mn
Dec 31, 2017 7.55 Mn
Sep 30, 2017 9.27 Mn
Sep 30, 2017 9.27 Mn
Jun 30, 2017 10.99 Mn
Jun 30, 2017 10.99 Mn
Mar 31, 2017 12.71 Mn
Mar 31, 2017 12.71 Mn
Dec 31, 2016 13.81 Mn
Dec 31, 2016 13.81 Mn